Zealand Pharma convenes its Annual General Meeting 2024
Company Announcement – No. 10 / 2024…
424,325DKK
0,91%
Echtzeit-Aktienkurs Zealand Pharma A/S
Bid:
Ask:
Nachrichten zur Zealand Pharma A/S Aktie
Zealand Pharma stock soars 35% on strong trial results for its weight loss treatment By Investing.com
Zealand Pharma stock soars 35% on strong trial results for its weight loss treatment…
Abnehmmittel: Boehringers Diätspritze wirkt in Studie auch gegen Fettleber
Der potentielle Konkurrent des Erfolgsprodukt Ozempic von Novo Nordisk wird gemeinsam mit der dänischen Firma Zealand Pharma erforscht. Der Studienerfolg…
Novo Nordisk and Eli Lilly rival soars 32% after promising weight-loss drug results
Zealand Pharmas Phase 2 trial was an "uniquivocal win" for a drug that can treat both liver disease and obesity,…